MoCRA Small-Business Exemptions for Cosmetics Companies

Introduction

Small cosmetic brands often hear a simplified version of MoCRA: “if you are small, you are exempt.” That is not how the rule works in practice. MoCRA includes a small-business exemption, but it is conditional, and it does not apply across all cosmetic product types or all compliance duties. FDA registration and listing guidance

For foreign beauty brands, the practical mistake is usually treating company size as the whole answer. FDA’s framework asks a narrower question: whether the business qualifies for the exemption, whether any of its products fall into carved-out categories, and which obligation is being analyzed — facility registration, product listing, or another MoCRA duty that still applies even if registration and listing do not. FDA MoCRA overview

This page is for founders, operations leads, and regulatory managers at foreign cosmetic companies that are trying to decide whether “small business” actually changes their U.S. filing obligations. It explains the rule structure, the product categories that usually break the exemption, and the facts you should gather before reaching a conclusion.

What usually matters most

MoCRA’s small-business exemption can apply to facility registration and product listing, but not to every cosmetic compliance duty. FDA MoCRA overview
The exemption does not apply if the facility manufactures or processes, or the responsible person markets, certain higher-scrutiny product types such as products used around the eye’s mucus membrane, injected products, internal-use products, or products intended to alter appearance for more than 24 hours when removal by the consumer is not part of normal use. FDA registration and listing guidance
The same brand can have some products that keep the exemption analysis simple and others that make it much harder. A broad product line is often where founders discover that “small business” was not the deciding fact after all.
Even when a small-business exemption applies, cosmetic products still need to be safe and properly labeled, and other role-based MoCRA obligations may still matter. FDA cosmetics law overview

What the small-business exemption actually does

Under FDA’s current MoCRA materials, certain small businesses are exempt from cosmetic facility registration and cosmetic product listing. Certain small businesses are exempt from good manufacturing practice requirements on FDA’s MoCRA overview page. That does not mean the company is outside MoCRA altogether, and it does not mean FDA approval is unnecessary because cosmetics generally are not “FDA-approved” before marketing in the way many first-time exporters assume. FDA MoCRA overview FDA small-business fact sheet

The useful mental model is this: the exemption is a carve-out from specific filing and operational requirements, not a blanket release from U.S. cosmetic law. If a brand is selling cosmetics into the United States, it still needs to think about product classification, safety substantiation, labeling, adverse event obligations where applicable, and whether a U.S.-based Responsible Person or U.S. Agent role is needed for its structure. FDA cosmetics law overview FDA Entry Point’s Responsible Person vs. U.S. Agent explainer

When the exemption does not apply

The most important limitation is product-based. FDA says the small-business exemption does not apply to facilities that manufacture or process, or responsible persons for, the following cosmetic products:

Products that regularly come into contact with the mucus membrane of the eye under customary or usual conditions of use
Products that are injected
Products intended for internal use
Products intended to alter appearance for more than 24 hours under customary or usual conditions of use, where removal by the consumer is not part of those conditions of use

That list is where many “small brand” assumptions fail. Eye-area products, certain long-wear products, and products that move outside ordinary topical cosmetic use can pull a company back into registration and listing obligations even if the business itself is small. FDA also notes that separate exemptions exist for certain products and facilities already subject to drug or device requirements, which means classification questions can matter just as much as revenue or headcount. FDA registration and listing guidance FDA small-business fact sheet

Facility registration and Responsible Person analysis are related, but not identical

Buyers often collapse these into one question. FDA does not. Facility registration focuses on the manufacturing or processing site. Product listing is submitted by the Responsible Person, which FDA defines as the manufacturer, packer, or distributor whose name appears on the product label. FDA registration and listing overview FDA final guidance PDF

That distinction matters because a foreign brand may outsource manufacturing, use a contract packer, or sell through a U.S. distributor while still having its own name on the label. In those cases, the facts that determine whether a facility must register are not always the same facts that determine who the Responsible Person is or whether a listing must be submitted. A pattern worth naming: the exemption question is often less about company size than about who is on the label, what the product is, and where it is made.

FDA’s guidance also notes a practical filing consequence: if a facility is a small business exempt from registration and therefore has no facility registration number, the product listing can instead provide the facility’s name and address. That is a useful clue that FDA expects companies to analyze facility status and listing status together, not as isolated boxes. FDA cosmetics news update

What facts to gather before deciding you are exempt

Most wrong calls happen because the company never assembled the underlying facts. Before treating your brand as exempt, gather evidence on these points:

Product catalog by use case: identify which SKUs are eye-area, long-wear, internal-use, injected, or otherwise close to the carved-out categories.
Label ownership: confirm whose name appears on the label, because that affects Responsible Person analysis. FDA final guidance PDF
Manufacturing map: list every facility that manufactures or processes the products sold into the U.S., including contract manufacturers and packers.
Product classification: flag any product that may be both a cosmetic and a drug because of claims, ingredients, or intended use. FDA’s small-business fact sheet is explicit that drug or cosmetic-drug products follow different rules. FDA small-business fact sheet
U.S. market structure: document whether you sell directly, through a U.S. distributor, or through a private-label arrangement, because that can change who carries which filing responsibility.
Supporting identifiers: if you are registering, FDA uses the FEI as the facility registration number for cosmetic facility registration. FDA guidance document page

Where the analysis usually gets harder than founders expect

The hard cases are rarely about obvious size. They are about borderline product categories and mixed portfolios. A skincare brand with ordinary cleansers and moisturizers may have a cleaner exemption analysis than a similarly sized brand that also sells lash products, long-wear tints, or products whose claims start to sound therapeutic.

Another common complication is role confusion. Foreign brands often ask whether having a U.S. Agent solves MoCRA Responsible Person obligations, or whether a Responsible Person eliminates the need for a U.S. Agent. Those are different roles, and the answer depends on the product category and filing context. For cosmetics specifically, FDA Entry Point offers both U.S. Agent support and MoCRA Responsible Person designation services for foreign brands entering the U.S. market. FDA Entry Point FDA Entry Point’s cosmetic MoCRA page

Where individual facts are disputed, cross-border, or structurally unusual — for example, split-label arrangements, hybrid cosmetic/drug positioning, or contract manufacturing across multiple countries — qualified regulatory or legal analysis is often the safer next step than relying on a generic “small business” checklist.

FDA Entry Point is a strong fit when the exemption question is tied to actual filing work

This is usually not a fit question about abstract legal theory. It is a workflow question: do you need someone to determine what has to be filed, act in the required U.S. role, and keep the registration and listing calendar from slipping once the answer is known? FDA Entry Point works with foreign manufacturers across cosmetics, food, drugs, and devices, and its cosmetics support includes U.S. Agent services, Responsible Person designation, facility registration, product listing, and label review. FDA Entry Point FDA Entry Point overview

For small and mid-size foreign beauty brands without an in-house regulatory team, that full-stack model is often more practical than treating exemption analysis as a one-time question. The operational risk is not just filing the wrong thing once; it is misunderstanding which products or role assignments pull the company back into ongoing obligations later.

Frequently asked questions

Do Korean skincare brands need MoCRA registration before selling in the U.S.?

Many do, but not all, because MoCRA registration and listing depend on the product type, the facility, and whether a small-business exemption actually applies. A foreign skincare brand cannot assume that being small removes the duty automatically, especially if any products fall into carved-out categories or raise classification issues. FDA’s registration and listing guidance is the starting point, and foreign brands also need to sort out Responsible Person and U.S. market structure questions. FDA registration and listing guidance

Can my U.S. Agent also act as my MoCRA Responsible Person?

Yes, sometimes, but the roles are not interchangeable by default. The Responsible Person is the manufacturer, packer, or distributor whose name appears on the cosmetic label, while a U.S. Agent is a separate regulatory contact role used in other FDA contexts and can matter for foreign companies more broadly. If one service provider is taking both roles, the label structure and contractual setup need to support that arrangement. FDA registration and listing guidance FDA Entry Point’s role comparison page

Is there a fee to register cosmetic products with the FDA?

FDA’s current cosmetics registration and listing materials do not frame MoCRA cosmetic facility registration and product listing as a user-fee program in the way some other FDA programs are. That said, brands still incur internal or service-provider costs to prepare filings, gather data, and maintain updates. The practical budget question for small foreign brands is usually service cost and compliance scope, not an FDA filing fee line item. FDA registration and listing guidance

What happens if my cosmetics brand has a Responsible Person but no U.S. Agent?

That may be acceptable for some cosmetic workflows, because Responsible Person and U.S. Agent are different roles with different legal functions. The real question is not whether one title exists, but whether your product category, import structure, and FDA-facing obligations require both roles somewhere in the chain. Foreign brands that assume one role covers the other often discover the gap only when a filing, import, or communication issue surfaces. FDA Entry Point’s role comparison page